IFNG and tuberculosis: In the Russian study published in 2018 [53] on the assessment of the cost-effectiveness for IFN-γ, a positive impact on the budget from the use of IFN-γ as a part of complex TB therapy was demonstrated due to reducing the duration of hospitalization.